Valuation: PetIQ, Inc.

Market Cap 919M 788M 736M 675M 1.27B 87.86B 1.29B 8.69B 3.4B 44.06B 3.45B 3.38B 146B P/E 2022
-5.58x
P/E 2023 282x
Enterprise Value 1.27B 1.09B 1.02B 934M 1.76B 121B 1.79B 12.01B 4.7B 60.93B 4.77B 4.67B 201B EV / Sales 2022
0.69x
EV / Sales 2023 0.84x
Free-Float
91.62%
Yield 2022 *
-
Yield 2023 -
3 years 15.09
Extreme 15.09
31.06
5 years 6.66
Extreme 6.66
31.06
10 years 6.66
Extreme 6.66
46
Manager TitleAgeSince
Chief Executive Officer 55 17/02/2025
President 39 01/02/2025
Director of Finance/CFO 62 03/01/2022
Director TitleAgeSince
Director/Board Member 70 25/10/2024
Director/Board Member - 25/10/2024
Director/Board Member - 25/10/2024
Date Insider Type Main position Quantity % Market Cap.
25/10/24 Issuer sale

Director

10,180 0.0343%
25/10/24 Issuer sale

Director

22,650 0.0763%
25/10/24 Issuer sale

Director

18,925 0.0638%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-.--%-.--%+55.76% 919M
+3.68%+1.77%-49.66%-57.77% 30.56B
+3.64%+7.79%+38.42%+110.84% 11.81B
-2.19%0.00%-17.85%+5.74% 3.95B
+0.15%-2.79%-1.64%+21.28% 3.2B
-2.52%-4.09%+47.53%+37.20% 2.18B
+0.86%-0.14%+12.40%+11.90% 1.94B
+2.28%+3.99%+13.41%+133.93% 1.41B
-2.28%+1.60%-19.96%+4.19% 1.27B
-1.91%+1.06%-11.76%-42.95% 1.03B
Average +0.01%-0.72%+1.09%+28.01% 5.83B
Weighted average by Cap. +1.65%-0.42%-17.69%-1.05%

Financials

2022 2023
Net sales 922M 790M 738M 677M 1.27B 88.08B 1.29B 8.71B 3.41B 44.17B 3.46B 3.38B 146B 1.1B 945M 883M 810M 1.52B 105B 1.55B 10.42B 4.08B 52.83B 4.14B 4.05B 175B
Net income -48.21M -41.35M -38.61M -35.43M -66.62M -4.61B -67.72M -456M -178M -2.31B -181M -177M -7.64B 2.13M 1.83M 1.71M 1.57M 2.94M 204M 2.99M 20.14M 7.89M 102M 8M 7.83M 338M
Net Debt 371M 318M 297M 272M 512M 35.43B 521M 3.5B 1.37B 17.77B 1.39B 1.36B 58.75B 352M 302M 282M 259M 486M 33.64B 494M 3.33B 1.3B 16.87B 1.32B 1.29B 55.78B
Logo PetIQ, Inc.
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Employees
1,527
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. PETQ Stock